The Potential Prognostic Performance of Neutrophil CD64 and Monocyte HLA-DR in Patients with Complicated Intra-abdominal Infections

Author(s): Evgeni Dimitrov*, Krasimira Halacheva, Emil Enchev, Georgi Minkov, Yovcho Yovtchev

Journal Name: Current Immunology Reviews (Discontinued)

Volume 16 , Issue 1 , 2020


Graphical Abstract:


Abstract:

Background: Complicated intra-abdominal infections are still associated with a high risk of an unfavorable outcome. Despite the equal treatment, the mortality rates in some patients’ populations remain significant, especially when the impaired immune response is present.

Aim: The object of this research is to analyze the impact of pro-inflammatory neutrophil CD64 and anti-inflammatory monocyte HLA-DR on the final outcome.

Methods: We have searched in the PubMed database, the literature relating the prognostic value of two biomarkers - nCD64 and mHLA-DR in patients with complicated intra-abdominal infections and/or sepsis.

Results: Eighteen original studies with 2960 patients fulfilled our inclusion criteria. The data about nCD64 that we found was contradictory, whereas low mHLA-DR expression showed good prognostic value.

Conclusion: Our review showed heterogeneous data about nCD64 survival prediction. Further investigations with surgical patients exclusively are needed to evaluate its prognostic value in cIAIs. However, we observed a good prognostic performance of low mHLA-DR expression. After a validation in larger multicentre studies, mHLA-DR could be used as promising prognostic biomarker in cIAIs.

Keywords: Intra-abdominal infections, CD64, HLA-DR, sepsis, outcome, mortality.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 16
ISSUE: 1
Year: 2020
Published on: 22 December, 2020
Page: [12 - 17]
Pages: 6
DOI: 10.2174/1573395516666200312111456
Price: $65

Article Metrics

PDF: 11